Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
David A Bergin, Killian Hurley, Adwait Mehta, Stephen Cox, Dorothy Ryan, Shane J O’Neill, Emer P Reeves*, Noel G McElvaney*Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin, Ireland*Thes...
Guardado en:
Autores principales: | Bergin DA, Hurley K, Mehta A, Cox S, Ryan D, O’Neill SJ, Reeves EP, McElvaney NG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/27554a9fd28f42fd81d6136662d4bb6d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
por: Vega-Carrascal I, et al.
Publicado: (2012) -
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
por: Jennifer L Taylor-Cousar, et al.
Publicado: (2010) -
Non-cystic fibrosis bronchiectasis in the elderly: current perspectives
por: Quinn TM, et al.
Publicado: (2018) -
The immunomodulatory effect of inhaled granulocyte-macrophage colony-stimulating factor in cystic fibrosis. A new treatment paradigm
por: Heslet L, et al.
Publicado: (2012) -
Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities
por: Hayoung Choi, et al.
Publicado: (2021)